![](https://www.worldpharmatoday.com/images/nBanners/Docuvera-728x90.jpeg")
Eli Lilly and Company received FDA approval for Cymbalta
Eli Lilly and Company announced that the U.S. Food and Drug Administration (FDA) has approved...
Eli Lilly to Open a Diabetes-Focused Research Center in China
Eli Lilly and Company announced plans to open a research center focused on diabetes in...
GlaxoSmithKline receives approval in Japan from the Ministry of Health
GlaxoSmithKline announced that it has received approval in Japan from the Ministry of Health, Labour...
Dako and Quintiles form alliance to speed development of personalized medicine
Dako, a Danish-based world leader in tissue-based cancer diagnostics, and Quintiles, the world’s leading bio...
Pfizer’s Lyrica® (Pregabalin) Capsules CV Receives Approval for Treatment of Peripheral Neuropathic Pain In...
Pfizer Inc announced today that the Japanese Ministry of Health, Labour and Welfare approved...
PRADAX gains approval in Canada for stroke prevention in atrial fibrillation
Health Canada, the Canadian health authority, has approved PRADAX™ (dabigatran etexilate), 1 Boehringer Ingelheim’s novel,...
Significant Milestone for Tengion Clinical Program Currently Enrolling Bladder Cancer Patients
Tengion, Inc., a leader in regenerative medicine, announced that surgeons at the University of Chicago...
AstraZeneca initiates phase IIB study for AZD9773 (CytoFab) as a treatment for severe sepsis
AstraZeneca announced that it has commenced dosing patients in a global Phase IIb study to...
Cipla launches the world’s first generic Pirfenidone in India
Cipla, among the world's leading generic pharmaceutical companies has introduced Pirfenidone in India; under the...
Sandoz announces launch of piperacillin and tazobactam for injection, a generic version of Zosyn
Sandoz anounced the launch of piperacillin and tazobactam for injection, a generic equivalent of Zosyn®,...